Tough Times for Pharma A Boon for Skin Care?

Changes in the pharmaceutical industry may be driving companies to prescription pharmaceutical drugs where demand is stronger, according to a report from market research firm Kalorama Information. 
 
“Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities,” said Bruce Carlson, publisher of Kalorama Information.  “By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology.”
 
Kalorama thinks this transition will play a role in the future development of the dermatological industry over the next five years, as  pharma companies need to get creative in an environment of financial difficulty and patent losses. 
 
The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products.